论文部分内容阅读
Small cell carcinoma of the cervix(SCCC)belongs to the neuroendocrine carcinomas,and it is a rare gynecological tumor of high-potential malignancy.It has a poorer prognosis compared to cervical squamous cancer or adenocarcinoma,and the therapeutic regimen of the disease differs.Diagnosis is based on pathomorphological characteristics,i.e.,the small and round cancer cel s(oat cel)which are uniform in shape and size,with the immunohistochemical marker helpful for diagnosis.Combined therapy is first recommended.Postoperative chemotherapy with platinum/etoposide (PE),vincristine/adriamycin/cyclophosphamide(VAC)and taxel/carboplatin (TP)can markedly improve the prognosis of early SCCC patients.
Small cell carcinoma of the cervix (SCCC) belongs to the neuroendocrine carcinomas, and and is a rare gynecological tumor of high-potential malignancy. It has a poorer prognosis compared to cervical squamous cancer or adenocarcinoma, and the therapeutic regimen of the disease differs. Diagnosis is based on pathomorphological characteristics, ie, the small and round cancer cel s (oat cel) which are uniform in shape and size, with the immunohistochemical markers helpful for diagnosis. Catedined is first recommended. Postoperative chemotherapy with platinum / etoposide (PE ), vincristine / adriamycin / cyclophosphamide (VAC) and taxel / carboplatin (TP) can markedly improve the prognosis of early SCCC patients.